Cargando…

Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer

PURPOSE: The purpose of this study was to evaluate the correlation between the expression of claudins and prognostic factors in patients with prostate cancer. MATERIALS AND METHODS: The subjects of this study were 48 patients who had undergone surgery for prostate cancer. The Gleason score (6 or low...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Kyung Won, Kwon, Young Kee, Kim, Byung Hoon, Kim, Chun Il, Chang, Hyuk Soo, Choe, Mi Sun, Park, Choal Hee
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858850/ https://www.ncbi.nlm.nih.gov/pubmed/20428425 http://dx.doi.org/10.4111/kju.2010.51.4.239

Ejemplares similares

Expression of Claudin-1 and -7 in Clear Cell Renal Cell Carcinoma and Its Clinical Significance
por: Shin, Hong Il, et al.
Publicado: (2011)

Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer
por: Jung, Seok Jin, et al.
Publicado: (2011)

The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)

Cyclooxygenase-2 Overexpression in Chronic Inflammation Associated with Benign Prostatic Hyperplasia: Is It Related to Apoptosis and Angiogenesis of Prostate Cancer?
por: Kim, Byung Hoon, et al.
Publicado: (2011)

The Efficacy of the EORTC Scoring System and Risk Tables for the Prediction of Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer after Intravesical Bacillus Calmette-Guerin Instillation
por: Seo, Kyung Won, et al.
Publicado: (2010)

Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia
por: Shin, Hong Il, et al.
Publicado: (2011)

α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
por: Shin, Teak Jun, et al.
Publicado: (2012)

Early Experience With Active Surveillance in Low-Risk Prostate Cancer Treated
por: Ha, Ji Yong, et al.
Publicado: (2014)

Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011)

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up
por: Ha, Ji Yong, et al.
Publicado: (2017)

High Expression of Claudin-4 Is Associated with Synchronous Tumors in Patients with Early Gastric Cancer
por: Kim, Won Shik, et al.
Publicado: (2022)

Effect of Overexpression of Glucose-Regulated Protein 78 and Bcl-2 on Recurrence and Survival in Patients With Ureter Tumors
por: Park, Chang Hyun, et al.
Publicado: (2013)

Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Relationship Between Spontaneous Passage Rates of Ureteral Stones Less Than 8 mm and Serum C-Reactive Protein Levels and Neutrophil Percentages
por: Park, Chang Hyun, et al.
Publicado: (2013)

Prognostic Significance of Claudin 4 in Completely Resected Adenocarcinoma of the Lung
por: Chae, Min Cheol, et al.
Publicado: (2014)

Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
por: Kim, Hyung-Don, et al.
Publicado: (2023)

Response to Comment on “Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis”
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Emerging Roles of Claudins in Human Cancer
por: Kwon, Mi Jeong
Publicado: (2013)

Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer
por: Orea, María J., et al.
Publicado: (2023)

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020)

Expression and significance of PTEN and Claudin-3 in prostate cancer
por: Ye, Xinglong, et al.
Publicado: (2019)

Immunoexpression of Claudins -3, -4 and -7 in prostate adenocarcinomas
por: Popescu, Tudor Cristian Timotei, et al.
Publicado: (2023)

The Role of Barrier Dysfunction and Change of Claudin Expression in Inflammatory Bowel Disease
por: Kim, Tae Il
Publicado: (2015)

Claudins in kidney health and disease
por: Jo, Chor ho, et al.
Publicado: (2022)

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
por: Jin, Byung-Soo, et al.
Publicado: (2015)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

Claudin-7 is Highly Expressed in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma
por: Choi, Yoo Duk, et al.
Publicado: (2007)

Clinical Characteristics and Prognostic Factors of Stress-Induced Cardiomyopathy
por: Lee, Jun-Won, et al.
Publicado: (2010)

Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis
por: Georges, Rania, et al.
Publicado: (2012)

Changes in Language Function and Recovery-Related Prognostic Factors in First-Ever Left Hemispheric Ischemic Stroke
por: Kim, Kyung Ah, et al.
Publicado: (2019)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
por: Kwon, Mi Jung, et al.
Publicado: (2017)

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
por: Yang, Hobin, et al.
Publicado: (2019)

Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
por: Arnold, A., et al.
Publicado: (2020)

Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
por: Kojima, Manabu, et al.
Publicado: (2020)

Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022)

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens
por: Cho, In-Chang, et al.
Publicado: (2011)

Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study
por: Park, Jung Ho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_35eo5lsph5anf0iro3oahbqi22